Prostate Adenocarcinoma — Trials

Prostate Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

433 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 62
Ph III recruiting: 5
Growth YoY: —
Industry share: 5%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (71)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04377152	Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer	approved for marketing	—	—	University of California, San FranciscoOTHER	1	Mar 1, 2021	clinicaltrials

Data updated 22 days agoSource updated Mar 1, 2021source: clinicaltrials